Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2501-2510 of 2808 for

Edit search filters
  1. A Study to Evaluate Effectiveness and Quality of Life Outcomes of Daratumumab in Relapsed/Refractory Multiple Myeloma Patients

    Rochester, MN

  2. Collection of Lung Tumor Tissue for Current and Future Investigations into Lung Cancer Biology, Pathophysiology, and Epidemiology

    Jacksonville, FL

  3. Institutional Analysis of Non-metastatic Pancreatic Adenocarcinoma Outcomes from 2011-2016

  4. A Study to Better Understand Carcinogenetic Progression in Cholangiocarcinoma

    Rochester, MN

  5. Prognostic and Predictive Biomarkers in Neuroendocrine Tumors

    Rochester, MN

  6. A Study to Evaluate the Role of Gut Microbiome in Cancer Therapy

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. A Study to Develop a Cohort Database and Study Platform in Breast Cancer Survivors Using Multiscale Omics

    Rochester, MN

  8. Return of Actionable Variants Empirical

    Rochester, MN

  9. cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR)

    Rochester, MN

  10. A Study to Review the Safety of Familial Adenomatous Polyposis/Erlotinib Study

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer